biguanides has been researched along with Coronary Heart Disease in 8 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our results conclude that 10% decrease in body mass index (BMI) among overweight patients, smoking cessation, initiation to undertake a preventive treatment with low-dose aspirin, initiation to undertake or intensify blood pressure control, initiation to undertake or intensify lipidic control, and shift to biguanides among overweight patients are factors associated with significant benefits (avoided costs) which compensate for the increase in treatment costs." | 3.73 | [Assessment of the budgetary impact of treatment guidelines in type II diabetes mellitus in France]. ( Crainich, D; Lebrun, T; Marissal, JP; Sailly, JC, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marissal, JP | 1 |
| Sailly, JC | 1 |
| Crainich, D | 1 |
| Lebrun, T | 1 |
| Fisman, EZ | 1 |
| Motro, M | 1 |
| Tenenbaum, A | 1 |
| Nicholson, PA | 1 |
| Breidahl, HD | 1 |
| Ennis, GC | 1 |
| Martin, FI | 1 |
| Stawell, JR | 1 |
| Taft, P | 1 |
| Gormsen, J | 1 |
| Fearnley, GR | 3 |
| Chakrabarti, R | 1 |
| Hocking, ED | 1 |
| Evans, J | 1 |
2 reviews available for biguanides and Coronary Heart Disease
| Article | Year |
|---|---|
Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
Topics: Benzamides; Biguanides; Coronary Disease; Diabetic Angiopathies; Drug Therapy, Combination; Humans; | 2008 |
Insulin and oral hypoglycaemic agents. II. Clinical and therapeutic aspects.
Topics: Administration, Oral; Adult; Biguanides; Blood Glucose; Coronary Disease; Diabetes Complications; Di | 1972 |
6 other studies available for biguanides and Coronary Heart Disease
| Article | Year |
|---|---|
[Assessment of the budgetary impact of treatment guidelines in type II diabetes mellitus in France].
Topics: Adolescent; Adult; Aged; Aspirin; Biguanides; Cerebrovascular Disorders; Coronary Disease; Cost-Bene | 2005 |
Ischaemic heart-disease in diabetes.
Topics: Biguanides; Coronary Disease; Diabetes Complications; Humans; Sulfonylurea Compounds | 1972 |
Fibrinolytic activity and haemagglutination inhibition immunoassays.
Topics: Adult; Aged; Biguanides; Clofibrate; Coronary Disease; Ethylestrenol; Female; Fibrin; Fibrinogen; Fi | 1970 |
[Physiological and pharmacological aspects of fibrinolysis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arteriosclerosis Obliterans; Biguanides; Blood Coagulation | 1971 |
Fibrinolytic effect of biguanides.
Topics: Adult; Aged; Angina Pectoris; Arteriosclerosis Obliterans; Biguanides; Chlorpropamide; Coronary Dise | 1968 |
Pharmacological fibrinolysis in occlusive vascular disease and its relation to diabetes mellitus.
Topics: Biguanides; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Drug Synergism; Ethylestren | 1969 |